A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Clinical trial NCT05768386 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05768386
- Sponsor
- BioMarin Pharmaceutical
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2023-01-01
- Primary completion
- 2040-01-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.